Month: April 2018

Terumo and Quirem Medical welcome the positive reimbursement decision for QuiremSpheres® in the Netherlands

Terumo and Quirem Medical welcome an important milestone for QuiremSpheres® in the Netherlands and in Europe. QuiremSpheres® is now reimbursed for liver-dominant, non-resectable, colorectal liver metastases in the salvage setting[1]. The National Healthcare Institute (‘Zorginstituut’) concludes that radioembolization treatment with holmium-166 microspheres, which has been developed in the Netherlands, meets

Read More »